Detalles de la búsqueda
1.
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
N Engl J Med
; 384(19): 1800-1809, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979488
2.
One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study.
J Asthma
; 60(3): 616-624, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35707873
3.
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Respir Res
; 21(1): 264, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050928
4.
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res
; 21(1): 266, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050934
5.
Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
Respir Res
; 20(1): 288, 2019 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31856838
6.
Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study.
Inflamm Res
; 64(11): 903-15, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26342289
7.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Lancet Respir Med
; 11(5): 425-438, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702146
8.
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studies.
Immunotherapy
; 15(16): 1327-1340, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772607
9.
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.
Respir Res
; 13: 53, 2012 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22726593
10.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Lancet Respir Med
; 10(7): 650-660, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364018
11.
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
Trials
; 18(1): 12, 2017 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28069068
Resultados
1 -
11
de 11
1
Próxima >
>>